2-[6-(3-chloro-1,2,4-triazol-1-yl)-3-ethylsulfonyl-2-pyridinyl]-5-(trifluoromethylsulfonyl)-1,3-benzoxazole
C17H11ClF3N5O5S2 — CID 118616916
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-(3-chloro-1,2,4-triazol-1-yl)-3-ethylsulfonyl-2-pyridinyl]-5-(trifluoromethylsulfonyl)-1,3-benzoxazole
2-[6-(3-chloro-1,2,4-triazol-1-yl)-3-ethylsulfonyl-2-pyridinyl]-5-(trifluoromethylsulfonyl)-1,3-benzoxazole (PubChem CID 118616916) has the molecular formula C17H11ClF3N5O5S2 and a molecular weight of 521.89 g/mol. Its IUPAC name is 2-[6-(3-chloro-1,2,4-triazol-1-yl)-3-ethylsulfonyl-2-pyridinyl]-5-(trifluoromethylsulfonyl)-1,3-benzoxazole.
Molecular Properties
| Compound Name | 2-[6-(3-chloro-1,2,4-triazol-1-yl)-3-ethylsulfonyl-2-pyridinyl]-5-(trifluoromethylsulfonyl)-1,3-benzoxazole |
|---|---|
| PubChem CID | 118616916 |
| Molecular Formula | C17H11ClF3N5O5S2 |
| Molecular Weight | 521.89 g/mol |
| Exact Mass | 520.98 |
| IUPAC Name | 2-[6-(3-chloro-1,2,4-triazol-1-yl)-3-ethylsulfonyl-2-pyridinyl]-5-(trifluoromethylsulfonyl)-1,3-benzoxazole |
| SMILES | CCS(=O)(=O)c1ccc(-n2cnc(Cl)n2)nc1-c1nc2cc(S(=O)(=O)C(F)(F)F)ccc2o1 |
| InChI | InChI=1S/C17H11ClF3N5O5S2/c1-2-32(27,28)12-5-6-13(26-8-22-16(18)25-26)24-14(12)15-23-10-7-9(3-4-11(10)31-15)33(29,30)17(19,20)21/h3-8H,2H2,1H3 |
| InChIKey | NJPQTVDOOKCWNW-UHFFFAOYSA-N |
| XLogP | 3.21 |
| TPSA | 137.91 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 521.89 |
| LogP ≤ 5 | 3.21 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118616916 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.